Cargando…
The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up
AIMS: Cisplatin-based chemotherapy (CBCT) is essential in the treatment of metastatic testicular cancer (TC) but has been associated with long-term risk of cardiovascular morbidity and mortality. Furthermore, cisplatin can be detected in the body decades after treatment. We aimed to evaluate the lon...
Autores principales: | Bjerring, Anders W, Fosså, Sophie D, Haugnes, Hege S, Nome, Ragnhild, Stokke, Thomas M, Haugaa, Kristina H, Kiserud, Cecilie E, Edvardsen, Thor, Sarvari, Sebastian I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984731/ https://www.ncbi.nlm.nih.gov/pubmed/33152065 http://dx.doi.org/10.1093/ehjci/jeaa289 |
Ejemplares similares
-
Young athlete’s growing heart: sex differences in cardiac adaptation to exercise training during adolescence
por: Forså, Marianne Inngjerdingen, et al.
Publicado: (2023) -
Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome
por: Bucher-Johannessen, Cecilie, et al.
Publicado: (2019) -
Lifestyle among long-term survivors of cancers in young adulthood
por: Bøhn, Synne-Kristin H., et al.
Publicado: (2020) -
Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer
por: Thorsen, Lene, et al.
Publicado: (2017) -
Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors
por: Fung, Chunkit, et al.
Publicado: (2018)